← Leaderboards
Laurie E Sower
Chrysalis Biotherapeutics, Inc.
$2,394,540
Attributed
$4,789,079
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2013–18$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,789,079 · 1
By mechanism
R44$4,789,079 · 1
Top collaborators
- Darrell H. Carney5 shared
Most similar at Chrysalis Biotherapeutics, Inc.
Same institution · by research overlap
- Darrell H. Carney$3,043,203
- Laurie Sower$8,454,436
- Barbara Maria Olszewska-Pazdrak$648,663
- Barbara Olszewska-Pazdrak$199,757
Others in their field
Top investigators on “Meetings”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$566,636,343
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$296,614,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$204,659,093
- Peter B. Gilbert · Fred Hutchinson Cancer Center$167,167,617
Research focus
MeetingsPhase 1 StudyEmergency SituationLifePharmacodynamicsDermalDisastersDoseHealingIn VivoPeptidesPharmaceutical PreparationsBiological AvailabilityAnimal RuleAnimalsClinical TrialsAcetatesCessation Of LifeAnimal EfficacyExposure ToInjection Of Therapeutic AgentIntestinal CryptNuclearPrevent
Grant awards (5)
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2018 · AI · contact PI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2017 · AI · contact PI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2016 · AI · contact PI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$978,663
R44 · FY2014 · AI · contact PI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$810,416
R44 · FY2013 · AI · contact PI